期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (4)
Background:Microsampling is a technique that utilizes a very small volume of biological matrix, typically less than 50 & mu;L, for quantitatively ......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (6)
Background:This study aimed to investigate the pharmacokinetic/pharmacodynamic (PK/PD) target attainment of various tigecycline dosing regimens in rea......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (6)
Background: Sunitinib (SUN) malate is an oral, multitargeted, tyrosine kinase inhibitor approved for the treatment of metastatic renal cell carcinoma,......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (3)
Background:Considerable interpatient and interoccasion variability has been reported in tacrolimus pharmacokinetics (PK) in the pediatric renal transp......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (5)
Background:Orelabrutinib is a second-generation Bruton tyrosine kinase inhibitor that improves the management of B-cell malignancies. The objective of......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (5)
Background:Meropenem is a carbapenem antibiotic often used in pediatric intensive care units due to its broad spectrum of activity. Therapeutic drug m......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (2)
Therapeutic drug monitoring (TDM) results for ganciclovir in 12 different treatment episodes showed large intraindividual and interindividual variabil......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (2)
Tobramycin is widely used to treat pulmonary exacerbations of cystic fibrosis. Height has been previously found to be significantly more predictive of......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (5)
Background: Pompe disease is a rare genetic disorder caused by a deficiency of a lysosomal enzyme called acid alpha-glucosidase and is classified into......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (6)
Background: Routine therapeutic drug monitoring (TDM) relies heavily on measuring trough drug concentrations. Trough concentrations are affected not o......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (1)
Background:The general population widely uses herbal medicines, as they are regarded as effective and safe. St. John's wort, which is an effective her......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (2)
Purpose:Despite a better safety profile than illicit gamma-hydroxybutyric acid (GHB) and other GHB analogs, sodium oxybate continues to raise serious ......
期刊： THERAPEUTIC DRUG MONITORING, 2023; 45 (3)
Background:Although atorvastatin (ATV) is well-tolerated, patients may report muscle complaints. These are difficult to predict owing to high interind......
